Allergic rhinitis
Conditions
Interventions
High frequency treatment group:Acupuncture treatment 3 times a week
High frequency treatment group:Acupuncture treatment was performed once a week
Sponsors
Tsinghua University Yuquan Hospital (Tsinghua University Hospital of Integrated Chinese and Western Medicine)
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) The population in Beijing who meet the diagnostic criteria for moderate to severe persistent AR and are in the stage of symptom onset when seeking medical attention. (2) The severity of the disease is moderate to severe and the duration of the disease is = 1 year. (3) There are specific allergens or sensitive inhalants present and there is a clear personal medical history. (4) Age range: 18-70 years old. (5) The patient has clear mind and speech and can cooperate with acupuncture and moxibustion treatment. (6) Stop taking drugs related to AR treatment one week before participating in the experiment and prohibit taking Chinese and Western drugs for AR treatment during acupuncture treatment. (7) Voluntary participation signing of informed consent form good compliance able to cooperate with follow-up.
Exclusion criteria
Exclusion criteria: (1) Individuals who have had respiratory infections within the past two weeks. (2) Patients with acute sinusitis or active asthma. (3) Individuals with abnormal nasal structure or accompanied by nasal polyps. (4) I have taken antihistamines corticosteroids or antibiotics in the past week. (5) Received systemic hormone therapy within 6 months or specific immunotherapy within 1 year. (6) He has received acupuncture and moxibustion or traditional Chinese medicine treatment for allergic rhinitis within 2 weeks. (7) Patients with severe primary diseases such as cardiovascular cerebrovascular hepatic renal and hematopoietic systems as well as psychiatric disorders. (8) Pregnant or lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of AR episodes within 1 year of treatment;AR drug use score within 1 year post-treatment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Total Nasal Symptom Score;Total Non Nasal Symptom Score;Rhinoconjunctivitis Quality of Life Questionnaire;Eosinophil count level; | — |
Countries
China
Contacts
Public ContactJIE JI
Tsinghua University Yuquan Hospital (Tsinghua University Hospital of Integrated Chinese and Western Medicine)
Outcome results
None listed